SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Howard Williams who wrote (11715)1/8/2013 8:34:26 AM
From: NTTG2 Recommendations  Respond to of 13111
 
Yea, the study they needed to do for the past 2 years, why it took so long to get this started is hard to understand, particularly if the company is not going to connect this to the registration trial.



To: Howard Williams who wrote (11715)1/8/2013 10:07:26 AM
From: Mammon4 Recommendations  Read Replies (1) | Respond to of 13111
 
I think the Moffitt study if very exciting, both for cancer patients, and for Provectus's shareholders!